The present invention relates to compounds of Formula (I): wherein R
1
is as defined in the claims. The compounds have specific affinity for the GABA
A
receptor and are therefore useful in the treatment and prevention of diseases modulated by the α
1
- and α
2
-GABA
A
receptors.